A report has warned that delaying the hepatitis b vaccine in infants carries significant risks. However, there is uncertainty surrounding the issue, as some studies suggest that the vaccine at birth is best for protecting newborns, while others claim that changes to vaccination recommendations may lead to increased infections. The CDC's vaccine advisory committee has made new recommendations, but the specifics and implications of these changes are not clear.